Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Center for Cancer Therapeutic Innovation (CCTI) conducts phase I clinical trials for many types of solid tumor cancers. Patients and referring physicians are welcome to contact us for more information about current phase I clinical trials for cancer.
If you are a patient interested in finding out more about phase I trials, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.
If you are a physician interested in referring a patient to a phase I trial, please contact us using this secure online form, by calling 617-632-3332, via email at cctireferral@dfci.harvard.edu, or by fax at 617-632-2630.
CCTI New Patient Coordinator: cctireferral@dfci.harvard.edu
CCTI nursing contact: cctireferral@dfci.harvard.edu
Center for Cancer Therapeutic Innovation Dana-Farber Cancer Institute 450 Brookline Avenue, Yawkey 6 Boston, MA 02215
New Patient Appointments 877-442-3324
Clinical Trials Questions?
877-DF-TRIAL (877-338-7425)